Penumbra, which is set to become part of Boston Scientific this year, is running the trial to inform the treatment of a type of medium-vessel blockage.

Penumbra expands clinical research through the FORWARD stroke study while remaining part of the NYSE Composite with advanced ...

The recent class I recall of a Penumbra cardiac device used in mechanical thrombectomy procedures provides a case study for the shortcomings of the current 510(k) medical device clearance process and ...

Penumbra Inc. announced it has received CE Mark approval for its Red 72 Silver Label and Red 72 Silver Label with SendIt technolog ...

Penumbra’s computer assisted vacuum thrombectomy platform uses aspiration for clot removal during acute ischemic stroke treatment.

Boston Scientific, Medtronic and Stryker were among the companies to ink deals to move into markets that are expanding ...

Publicly traded global medical device company Penumbra expanded its portfolio to include virtual reality offerings through its REAL Immersive System in 2019. The system is designed to help clinicians ...

Jan 15 (Reuters) - Boston Scientific ‌agreed to buy medtech firm Penumbra in ‌a $14.5 billion deal on Thursday, its second‑largest takeover ever, as it looks to re-enter the neurovascular market and ...

Companies aim to introduce Penumbra’s most advanced peripheral mechanical thrombectomy technology to Japan upon regulatory approval Lightning technology is designed for single session blood clot ...